CN102845529A - Composite probiotic fermented soybean milk beverage for effectively reducing blood lipid and preparation method - Google Patents
Composite probiotic fermented soybean milk beverage for effectively reducing blood lipid and preparation method Download PDFInfo
- Publication number
- CN102845529A CN102845529A CN201210005614XA CN201210005614A CN102845529A CN 102845529 A CN102845529 A CN 102845529A CN 201210005614X A CN201210005614X A CN 201210005614XA CN 201210005614 A CN201210005614 A CN 201210005614A CN 102845529 A CN102845529 A CN 102845529A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus casei
- milk beverage
- preparation
- milk
- soybean milk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A composite probiotic fermented soybean milk beverage for effectively reducing blood lipid is characterized in that the beverage comprises the following ingredients: 300 kg of soybean milk or soybean powder reconstituted milk, 10-15 kg of glucose, 100-120 kg of cane sugar, 2-4 kg of stabilizing agents, 0.1-0.3 kg of acid solutions, 0.1-0.3 kg of edible essence or flavor, 0.015-0.03 kg of lactobacillus casei Zhang starters, and 0.015-0.3 kg of bifidobacterium animalis subsp. lactis V9 starters. The starter bacterial strains are preserved in China general microbiological culture collection center with a preservation number of CGMCC No. 5469 and CGMCC No. 5470. The invention also discloses the preparation method.
Description
Technical field
The present invention relates to effectively reduce composite probiotics ferment soyabean milk beverage and the preparation method of blood fat.
Background technology
Blood fat is the general designation of contained lipid in the blood plasma, mainly comprises triglycerides, cholesterol, phosphatide, glycolipid, sterol and steroids etc.The variation of blood fat is mainly employed the how much relevant of fat depot with what and body of body fat content, reacts to a great extent the situation of body metabolism fat.In recent years, crowd's blood lipid level is totally raising year by year.Its reason mainly contains, and people take in every day is rich in high protein, high-fat food increases; The improvement of people's condition of work, momental minimizing, body fat is difficult to dissolve; Operating pressure increases, and the endocrine situation changes, and body fat is piled up.According to statistics, China more than 18 years old the dyslipidemia crowd reached 1.6 hundred million.In the crowd more than 35 years old, there are 2,500 ten thousand people to suffer from simultaneously hyperlipidemia.Dyslipidemia rises to original 3-5 doubly to the danger of Chinese people.The large investigation of Second Committee Chinese city health status of recently announcing shows nearly half dyslipidemia in China's Young crowd.
High fat of blood has become a kind of common property, multiple diseases, is the key factor of bringing out the illnesss such as coronary heart disease, artery sclerosis, cerebral vascular dementia, fatty liver, diabetes, cholecystitis, obesity, sexual deterioration.At present, reduce blood fat main path remain drug therapy, yet most of blood lipid-lowering medicines all have side effect more or less, wherein topmost is exactly lasting rising and the liver dysfunction that causes serum transaminase.Regulating by meals is the basic measures that reduce high fat of blood, and even now is done has certain effect, but the patient is difficult to adhere to for a long time and its effect can weaken in time.Therefore people attempt to reduce blood fat by other approach.One of them just is improved blood lipid metabolism effect and angiocardiopathy preventing the physiological function of known probio.In recent years, increasing people begins to pay close attention to the effect for reducing blood fat of probio.The viable bacteria goods that contain some probios are worth exploitation.
Summary of the invention
Main purpose of the present invention provides a kind of composite probiotics ferment soyabean milk beverage and preparation method of effective reduction blood fat.
Technical solution of the present invention is: effectively reduce the composite probiotics ferment soyabean milk beverage of blood fat, it is characterized in that composition is: Soybean Milk or soy meal recombined milk 300kg, glucose 10 ~ 15kg, sucrose 100 ~ 120kg, stabilizing agent 2 ~ 4kg, acid solution 0.1 ~ 0.3kg, flavoring essence or spices 0.1 ~ 0.3kg, Lactobacillus casei (Lactobacillus casei Zhang) leavening 0.015 ~ 0.03kg, Bifidobacterium (Bifidobacterium animalis subsp.lactis V9) leavening 0.015 ~ 0.03kg.Described leavening bacterial strain is preserved in China Committee for Culture Collection of Microorganisms common micro-organisms center, preservation address: No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, Classification And Nomenclature is respectively " Lactobacillus casei Lactobacillus casei " and " bifidobacterium animalis subspecies Bifidobacterium animalis subsp.lactis ", preservation date is on November 18th, 2011, and preserving number is respectively CGMCC No.5469 and CGMCC No.5470.
Effectively reduce the preparation method of the composite probiotics ferment soyabean milk beverage of blood fat, it is characterized in that comprising the following steps: accessing Lactobacillus casei (Lactobacillus casei Zhang) and Bifidobacterium (Bifidobacterium animalis subsp.lactis V9) in the mixture of Soybean Milk or soy meal recombined milk and liquid glucose, through fermentation, making the pH value is 3.9 ~ 4.1, namely gets product.
The Lactobacillus casei viable count is not less than 3.0 * 10 in the active probiotic soyabean milk beverage
8Cfu/mL, the number of active bifid bacteria is not less than 8.0 * 10
7Cfu/mL.
The invention has the beneficial effects as follows: the survival content of Lactobacillus casei and Bifidobacterium is high in the product of the present invention; can effectively reduce blood in human body in fat and cholesterol; recover the human normal function, the various illnesss of eliminating high fat of blood mass formed by blood stasis, hypercholesterolemia and causing thus.
The present invention is described further below in conjunction with drawings and Examples.
Description of drawings
Accompanying drawing is that oral composite probiotics ferment soyabean milk beverage is on the figure that affects of experimenter's blood lipids index.
The specific embodiment
Effectively reduce the composite probiotics ferment soyabean milk beverage of blood fat, composition is: Soybean Milk or soy meal recombined milk 300kg, glucose 10kg, sucrose 110kg, stabilizing agent 3kg, acid solution 0.1kg, flavoring essence 0.1kg, Lactobacillus casei (Lactobacillus casei Zhang) leavening 0.015kg, Bifidobacterium (Bifidobacterium animalis subsp.lactis V9) leavening 0.015kg.Described leavening bacterial strain is preserved in China Committee for Culture Collection of Microorganisms common micro-organisms center, and preserving number is respectively CGMCC No.5469 and CGMCC No.5470.
Effectively reduce the preparation method of the composite probiotics ferment soyabean milk beverage of blood fat, comprise the following steps: to access Lactobacillus casei (Lactobacillus casei Zhang) and Bifidobacterium (Bifidobacterium animalis subsp.lactis V9) in the mixture of Soybean Milk or soy meal recombined milk and liquid glucose, through fermentation, making the pH value is 3.9 ~ 4.1, add flavoring essence, namely get product.
The Lactobacillus casei viable count is not less than 3.0 * 10 in the active probiotic soyabean milk beverage
8Cfu/mL, the number of active bifid bacteria is not less than 8.0 * 10
7Cfu/mL.
Verify the effect for reducing blood fat of this product with human trial.Select 38 (30～40 years old persons: 4,40～50 years old persons: 20,50～60 years old persons: 6, person more than 60 years old: 8) hyperlipemic patients, wherein blood triglyceride (TG) person that exceeds the normal reference value is 33, cholesterol (TC) exceeds 10 of reference value persons, 18 of the high persons of LDL-C (LDL-C).Drink continuously this product 60d, detect the blood fat situation.Triglycerides in the hyperlipemic patients blood (TG), cholesterol (TC) and LDL-C (LDL-C) content obviously raise, and then cause hypertension, the various diseases such as cardiovascular.So the content of TG, TC and LDL-C in the mensuration blood can well be estimated the situation of blood fat.Measurement result is shown in subordinate list 1, table 2 and accompanying drawing, and in the accompanying drawing, 1 represents triglycerides (TG); 2 represent cholesterol (TC); 3 represent HDL-C (HDL-C); 4 represent LDL-C (LDL-C); 5 represent Apolipoprotein A1 (APO A1); 6 represent apolipoprotein B (APO B), and this product can effectively reduce the hyperlipemic patients blood lipid level.
The oral composite probiotics ferment soyabean milk beverage of table 1 is on the impact of experimenter's blood lipids index
The oral composite probiotics ferment soyabean milk beverage of table 2 is to the efficiency analysis of hyperlipemic patients
Claims (3)
1. effectively reduce the composite probiotics ferment soyabean milk beverage of blood fat, it is characterized in that composition is: Soybean Milk or soy meal recombined milk 300kg, glucose 10～15kg, sucrose 100～120kg, stabilizing agent 2～4kg, acid solution 0.1～0.3kg, flavoring essence or spices 0.1～0.3kg, Lactobacillus casei (Lactobacillus casei Zhang) leavening 0.015～0.03kg, Bifidobacterium (Bifidobacterium animalis subsp.lactis V9) leavening 0.015～0.03kg, described leavening bacterial strain is preserved in common micro-organisms DSMZ of China Committee for Culture Collection of Microorganisms, and preserving number is respectively CGMCC No.5469 and CGMCC No.5470.
2. the preparation method of the composite probiotics ferment soyabean milk beverage of effective reduction blood fat as claimed in claim 1, it is characterized in that comprising the following steps: accessing Lactobacillus casei (Lactobacillus casei Zhang) and Bifidobacterium (Bifidobacterium animalis subsp.lactis V9) in the mixture of Soybean Milk or soy meal recombined milk and liquid glucose, through fermentation, making the pH value is 3.9～4.1, namely gets product.
3. the preparation method of the composite probiotics ferment soyabean milk beverage of effective reduction blood fat as claimed in claim 2 is characterized in that the Lactobacillus casei viable count is not less than 3.0 * 10 in the active probiotic soyabean milk beverage
8Cfu/mL, the number of active bifid bacteria is not less than 8.0 * 10
7Cfu/mL.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210005614XA CN102845529A (en) | 2012-01-10 | 2012-01-10 | Composite probiotic fermented soybean milk beverage for effectively reducing blood lipid and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210005614XA CN102845529A (en) | 2012-01-10 | 2012-01-10 | Composite probiotic fermented soybean milk beverage for effectively reducing blood lipid and preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102845529A true CN102845529A (en) | 2013-01-02 |
Family
ID=47392826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210005614XA Pending CN102845529A (en) | 2012-01-10 | 2012-01-10 | Composite probiotic fermented soybean milk beverage for effectively reducing blood lipid and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102845529A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103947760A (en) * | 2014-04-04 | 2014-07-30 | 吉林农业大学 | Preparation method of weight-reducing lipid-lowering probiotics fermented soya-bean milk |
| EP2803362A1 (en) * | 2013-05-14 | 2014-11-19 | SciMar Ltd. | Hepatic insulin sensitizing substance and test meal for insulin sensitization |
| CN105039217A (en) * | 2015-07-16 | 2015-11-11 | 山东凤凰生物有限公司 | Hypoglycemic probiotic preparation and its preparation method |
| WO2017124590A1 (en) * | 2016-01-18 | 2017-07-27 | 青岛哈拿生物科技有限公司 | Preparation method and application of water-soluble natural nitric oxide |
| CN111575202A (en) * | 2020-05-19 | 2020-08-25 | 北京科拓恒通生物技术股份有限公司 | Lactobacillus casei for prevention and adjuvant therapy of type II diabetes and application thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1192332A (en) * | 1997-01-22 | 1998-09-09 | 不二制油株式会社 | Process for preparing fermented soybean milk |
| CN1919017A (en) * | 2006-08-31 | 2007-02-28 | 林伟锋 | Novel method for the production of soybean containing fermented milk products |
| CN1927005A (en) * | 2005-09-06 | 2007-03-14 | 天津科技大学 | Fermentation soybean milk with increasing compact bone substance density and inhibiting angiotensin converting enzyme function and method for preparing same |
| CN101642221A (en) * | 2009-08-31 | 2010-02-10 | 江苏大学 | Functional soy peptide fermented milk and preparation method thereof |
| CN102007968A (en) * | 2010-12-27 | 2011-04-13 | 内蒙古伊利实业集团股份有限公司 | Lactobacillus casei-containing active lactobacillus beverage and preparation method thereof |
| CN102845530A (en) * | 2012-01-10 | 2013-01-02 | 北京和美科盛生物技术有限公司 | Composite probiotic fermented soybean milk beverage for effectively relieving constipation and preparation method |
-
2012
- 2012-01-10 CN CN201210005614XA patent/CN102845529A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1192332A (en) * | 1997-01-22 | 1998-09-09 | 不二制油株式会社 | Process for preparing fermented soybean milk |
| CN1927005A (en) * | 2005-09-06 | 2007-03-14 | 天津科技大学 | Fermentation soybean milk with increasing compact bone substance density and inhibiting angiotensin converting enzyme function and method for preparing same |
| CN1919017A (en) * | 2006-08-31 | 2007-02-28 | 林伟锋 | Novel method for the production of soybean containing fermented milk products |
| CN101642221A (en) * | 2009-08-31 | 2010-02-10 | 江苏大学 | Functional soy peptide fermented milk and preparation method thereof |
| CN102007968A (en) * | 2010-12-27 | 2011-04-13 | 内蒙古伊利实业集团股份有限公司 | Lactobacillus casei-containing active lactobacillus beverage and preparation method thereof |
| CN102845530A (en) * | 2012-01-10 | 2013-01-02 | 北京和美科盛生物技术有限公司 | Composite probiotic fermented soybean milk beverage for effectively relieving constipation and preparation method |
Non-Patent Citations (2)
| Title |
|---|
| 张青等: "满益生菌Lactobacillus casei Zhang 和Bifidobacterium animalis V9在豆乳中生长及活性豆乳饮料中存活性研究", 《河套大学学报》, vol. 8, no. 4, 31 December 2011 (2011-12-31) * |
| 张青等: "益生菌干酪乳杆菌Zhang和双歧杆菌V9发酵豆乳的研究", 《乳业科学技术》, no. 1, 31 December 2010 (2010-12-31) * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2803362A1 (en) * | 2013-05-14 | 2014-11-19 | SciMar Ltd. | Hepatic insulin sensitizing substance and test meal for insulin sensitization |
| US9840547B2 (en) | 2013-05-14 | 2017-12-12 | Scimar Ltd. | Hepatic insulin sensitizing substance and test meal for insulin sensitization |
| AU2014202625B2 (en) * | 2013-05-14 | 2018-11-08 | Scimar Ltd. | Hepatic insulin sensitizing substance and test meal for insulin sensitization |
| CN103947760A (en) * | 2014-04-04 | 2014-07-30 | 吉林农业大学 | Preparation method of weight-reducing lipid-lowering probiotics fermented soya-bean milk |
| CN105039217A (en) * | 2015-07-16 | 2015-11-11 | 山东凤凰生物有限公司 | Hypoglycemic probiotic preparation and its preparation method |
| CN105039217B (en) * | 2015-07-16 | 2019-05-07 | 山东凤凰生物有限公司 | A kind of hypoglycemic probiotics preparation and preparation method thereof |
| WO2017124590A1 (en) * | 2016-01-18 | 2017-07-27 | 青岛哈拿生物科技有限公司 | Preparation method and application of water-soluble natural nitric oxide |
| CN111575202A (en) * | 2020-05-19 | 2020-08-25 | 北京科拓恒通生物技术股份有限公司 | Lactobacillus casei for prevention and adjuvant therapy of type II diabetes and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9750775B2 (en) | Lactic acid bacterium-containing preparation | |
| KR102323022B1 (en) | Sleep quality improver | |
| CN109628358B (en) | Composite probiotics and application thereof | |
| KR101040721B1 (en) | Composition for alleviation of alcohol-induced hangover comprising Hovenia dulcis Thunberg contained Ssangwhatang | |
| CN105192832A (en) | Composition of probiotic fermented horseradish tree leaves as well as preparation method and application of composition | |
| CN107981324A (en) | Turmeric fermented food and preparation method thereof | |
| KR20110041050A (en) | Composition containing extract of fermentated tea for improving circulation of blood and mitigating cold symptoms in hands and feet | |
| CN102845529A (en) | Composite probiotic fermented soybean milk beverage for effectively reducing blood lipid and preparation method | |
| JP2010132625A (en) | Anti-diabetic agent | |
| EP3781185B1 (en) | Method for alleviating tobacco or nicotine withdrawal symptoms | |
| CN101277712A (en) | The composition comprising extract of cinnamomum cassia bark for improving normal flora and enhancing immune response | |
| KR102606952B1 (en) | Method of Lactobacillus Plantarum TWK10 composition for improving inflammation or reducing body fat after exercise | |
| KR20200069249A (en) | Composition for preventing, improving or treating diabetes comprising Paeonia lactiflora extract fermented by lactic acid bacteria as effective ingredients | |
| CN104686682B (en) | It is a kind of with probiotics fermention milk beverage relaxed bowel with auxiliary lipid-lowering function and preparation method thereof | |
| CN106819719B (en) | Lactobacillus beverage with function of continuously controlling blood sugar and preparation method thereof | |
| WO2017183595A1 (en) | Fermented milk for ameliorating feeling of fatigue | |
| KR100918629B1 (en) | Composition for prevention or treatment of liver toxicity comprising lactic acid bacteria fermented Ssangwhatang | |
| CN102421299A (en) | Composition for improving blood circulation containing fermented tea, and pharmaceutical and health-food compositions comprising the same | |
| KR100988923B1 (en) | Composition for alleviation of alcohol-induced hangover comprising lactic acid bacteria fermented Ssangwhatang | |
| CN102845528A (en) | Composite probiotic fermented soybean milk beverage for effectively relieving alcoholic liver injury and preparation method | |
| KR102037108B1 (en) | Composition for Preventing or Treating Obesity Comprising Heat-killed Lactic Acid Bacteria or Yeast from Kefir | |
| CN102845530A (en) | Composite probiotic fermented soybean milk beverage for effectively relieving constipation and preparation method | |
| JP2008081434A (en) | Mood ameliorating agent | |
| TWI642363B (en) | Qol improving or sustaining agent | |
| WO2023166548A1 (en) | Agent for ameliorating symptoms of female menopause |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160126 Address after: 101407 No. 98, open road, Huairou Town, Huairou District, Beijing Applicant after: BEIJING KETUO HENGTONG BIOTECHNOLOGY DEVELOPMENT CO., LTD. Address before: 100102 Beijing City, Wangjing science and Technology Park in Chaoyang District Lize Park Building No. 106 305C-2 Applicant before: Beijing Hemei Kesheng Biological Technology Co.,Ltd. |
|
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130102 |
|
| RJ01 | Rejection of invention patent application after publication |